Keros Therapeutics Inc.
(KROS)
undefined
undefined%
At close: undefined
18.64
-1.01%
After-hours Dec 13, 2024, 07:59 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
Cash & Equivalents | 331.15M | 279.05M | 230.04M | 265.88M | 7.02M | 23.26M |
Short-Term Investments | - | - | - | - | - | - |
Long-Term Investments | 1.21M | 1.33M | 1.33M | 115.00K | 115.00K | 501.00K |
Other Long-Term Assets | 2.05M | 2.12M | 82.00K | - | - | - |
Receivables | 1.09M | 841.00K | 18.00M | 216.00K | 922.00K | - |
Inventory | - | -841.00K | 3.06M | 1.47M | 759.00K | - |
Other Current Assets | 15.05M | 5.88M | 3.20M | 1.63M | 985.00K | 2.27M |
Total Current Assets | 347.29M | 285.77M | 251.44M | 267.73M | 8.93M | 25.53M |
Property-Plant & Equipment | 19.47M | 17.57M | 2.40M | 1.60M | 1.91M | 1.38M |
Goodwill & Intangibles | - | - | - | - | - | - |
Total Long-Term Assets | 22.73M | 21.01M | 3.81M | 1.72M | 2.03M | 1.88M |
Total Assets | 370.02M | 306.78M | 255.25M | 269.44M | 10.96M | 27.41M |
Account Payables | 5.45M | 3.34M | 3.65M | 2.15M | 2.09M | 501.00K |
Deferred Revenue | - | - | 7.13M | 4.39M | 1.92M | 10.00M |
Short-Term Debt | 1.00M | 910.00K | 1.72M | 846.00K | 376.00K | 166.00K |
Other Current Liabilities | 17.92M | 12.25M | 6.37M | 4.00M | 1.98M | 518.00K |
Total Current Liabilities | 24.37M | 16.55M | 11.85M | 7.18M | 4.49M | 11.47M |
Long-Term Debt | 13.44M | 25.62M | 462.00K | 952.00K | 899.00K | 622.00K |
Other Long-Term Liabilities | - | -12.81M | -231.00K | -414.00K | 5.08M | 2.56M |
Total Long-Term Liabilities | 13.44M | 12.81M | 231.00K | 538.00K | 1.02M | 3.19M |
Total Liabilities | 37.81M | 29.36M | 12.08M | 7.72M | 5.50M | 14.65M |
Total Debt | 14.44M | 13.27M | 1.09M | 899.00K | 1.27M | 788.00K |
Common Stock | 3.00K | 2.00K | 2.00K | 2.00K | 2.00K | 1K |
Retained Earnings | -381.43M | -228.43M | -123.75M | -65.01M | -19.65M | -7.31M |
Comprehensive Income | 0.00 | -0.00 | -0.00 | -269.44M | -19.94M | -246.00K |
Shareholders Equity | 332.21M | 277.42M | 243.17M | 261.72M | 5.45M | 12.76M |
Total Investments | 1.21M | 1.33M | 1.33M | 115.00K | 115.00K | 501.00K |